By Regulatory Approvals — US FDA approves GSK's hepatitis B drug, offering patients chance to stop long-term treatment Reuters
Read the original at Regulatory Approvals ↗
Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. October 20, 2026.